跳至主要内容
临床试验/JPRN-UMIN000051443
JPRN-UMIN000051443
招募中
未知

Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease. - Exploration of Clinical Indicators Available for Evaluation of Clinical Trials for Chronic Kidney Disease.

Saitama Medical University0 个研究点目标入组 25 人2023年7月1日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Chronic Kidney Disease
发起方
Saitama Medical University
入组人数
25
状态
招募中
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年7月1日
结束日期
2025年8月31日
最后更新
2年前
研究类型
Observational
性别
All

研究者

入排标准

入选标准

  • 未提供

排除标准

  • (1\) Patients deemed inappropriate by the principal investigator (e.g., after introduction of renal replacement therapy, children (under 18 years old), acute kidney injury, unilateral renal disease (e.g., renal vascular hypertension), renal tumor, severe edematous disease (e.g., nephrotic syndrome), cystic disease, postrenal kidney disease) (2\) Patients who have changed the content of the given medication in the initial entry (At the time of the change in the content of the medication because the purpose is to confirm the baseline \[MRI, biomarkers] of the case.) (3\) Those whose MRI images or laboratory test results are deemed inappropriate for evaluation (When the renal parenchyma is poorly delineated on MRI due to artifacts from body movement, atrophy, cysts, scarring, etc., or when the specimen acquisition and processing process is inappropriate and is inferred not to reflect the pathophysiology of the subject)

结局指标

主要结局

未指定

相似试验